跳至主要内容
临床试验/NCT07207980
NCT07207980尚未招募不适用

Lifestyle Intervention Clinical Trial for the Remission of Type 2 Diabetes Mellitus in Primary Care (CREDOenAP)

Parc Sanitari Pere Virgili1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年1月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Presence of T2DM remission

研究概览

简要总结

The purpose of this clinical trial is to determine whether an intensive lifestyle intervention can achieve remission of type 2 diabetes mellitus (T2DM) in adult patients treated in primary care. The main questions the study seeks to answer are:

  • What proportion of participants achieve diabetes remission after 6 months of intervention?
  • How many participants maintain remission 12 months after completing the program (18 months total)?

Participants will:

  • Follow a personalized dietary plan with carbohydrate restriction.
  • Engage in moderate, accessible physical activity.
  • Implement strategies to improve circadian rhythm regularity.
  • Receive psychological counseling and support.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent.
  • Men and women aged 18-80 years, inclusive.
  • Confirmed diagnosis of T2DM according to recognized diagnostic criteria
  • Most recent recorded hemoglobin A1c (HbA1c) > 6.5%.
  • Body Mass Index (BMI) greater than 27 kg/m².

排除标准

  • Failure to meet the diagnostic criteria for T2DM in the screening laboratory tests.
  • Being dependent for basic activities of daily living (Barthel score ≤ 90 points).
  • Lack of willingness to cooperate with the follow-up of the lifestyle intervention plan.
  • Presence of serious or terminal comorbidities significantly worsening short- to medium-term prognosis (active cancer, terminal chronic diseases, myocardial infarction within the last 6 months, acute heart failure or NYHA stage ≥ III, etc.).
  • History of ketoacidosis.
  • Presence of criteria or potential autoimmune insulinopenia (abnormal C-peptide, anti-GAD+ antibodies, pattern of basal and/or glucose-stimulated hypoinsulinemia).
  • Cognitive impairment.
  • Weight loss exceeding 5 kg in the past 6 months.
  • Significant changes in physical activity and/or dietary patterns in the past 6 months.
  • History of eating disorders.
  • History of substance abuse.
  • History of severe psychiatric disorders.
  • Pregnancy or intention to become pregnant within the study period.

结局指标

主要结局

Presence of T2DM remission

时间窗: After 6 months of intervention and 12 months after the intervention

Glycated hemoglobin (HbA1c): T2DM remission will be considered if HbA1c is \< 6.5% after 6 months of intervention and at least 3 months without antidiabetic medication. HbA1c will be determined by blood analysis after a minimum of 8 hours of fasting Fasting plasma glucose: T2DM remission will be considered if fasting venous plasma glucose is \< 126 mg/dL after 6 months of intervention and at least 3 months without antidiabetic medication. Fasting plasma glucose will be measured by venous blood analysis after a minimum of 8 hours of fasting

次要结局

  • Total cholesterol(After 6 months of intervention and 12 months after the intervention)
  • Blood pressure(After 6 months of intervention and 12 months after the intervention.)
  • HDL cholesterol(After 6 months of intervention and 12 months after the intervention)
  • Presence and size of atherosclerotic plaques in carotid arteries(After 6 months of intervention and 12 months after the intervention)
  • LDL cholesterol(After 6 months of intervention and 12 months after the intervention)
  • Apolipoprotein B100 (ApoB100)(After 6 months of intervention and 12 months after the intervention)
  • Insulin resistance(After 6 months of intervention and 12 months after the intervention)
  • Triglycerides(After 6 months of intervention and 12 months after the intervention)
  • Weight(After 6 months of intervention and 12 months after the intervention)
  • Body Mass Index (BMI)(After 6 months of intervention and 12 months after the intervention)
  • Pancreatic activity(After 6 months of intervention and 12 months after the intervention)
  • Fasting insulin(After 6 months of intervention and 12 months after the intervention)
  • Abdominal circumference(After 6 months of intervention and 12 months after the intervention)
  • Metabolic Syndrome Diagnosis(After 6 months of intervention and 12 months after the intervention)
  • NAFLD Liver Fat Score(After 6 months of intervention and 12 months after the intervention)
  • NAFLD Fibrosis Score(After 6 months of intervention and 12 months after the intervention)
  • Physical activity(After 6 months of intervention and 12 months after the intervention)
  • Alcohol consumption(After 6 months of intervention and 12 months after the intervention)
  • Circadian habits(After 6 months of intervention and 12 months after the intervention)
  • Nutritional and energy composition:(After 6 months of intervention and 12 months after the intervention)
  • Smoking habits(After 6 months of intervention and 12 months after the intervention)
  • Health status(After 6 months of intervention and 12 months after the intervention)
  • Medication consumption(After 6 months of intervention and 12 months after the intervention)
  • Number of hypoglycemia episodes(During each follow-up telephone visit throughout the intervention, after 6 months of intervention and 12 months after the intervention)
  • Number of symptomatic hyperglycemia episodes(During each follow-up telephone visit throughout the intervention, after 6 months of intervention and 12 months after the intervention)
  • Total number of healthcare visits(During each follow-up telephone visit throughout the intervention, after 6 months of intervention and 12 months after the intervention)
  • Number of diabetes-related emergency episodes(During each follow-up telephone visit throughout the intervention, after 6 months of intervention and 12 months after the intervention)

研究者

发起方
Parc Sanitari Pere Virgili
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验